Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin J Drapkin

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Molecular Systems Biology|November 19, 2009
Analysis of the mitotic exit control system using locked levels of stable mitotic cyclinBenjamin J Drapkin, Ying Lu, Andrea L Procko, et al.
Molecular Cell|June 18, 2004
Targeted proteomic study of the cyclin-Cdk moduleVincent Archambault, Emmanuel J Chang, Benjamin J Drapkin, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|April 25, 2025
Myc family proteins: Molecular drivers of tumorigenesis and resistance in neuroendocrine tumorsHannah M Hylton-McComas, Alyssa Cordes, Konstantinos V Floros, et al.
Cancer|April 30, 2013
Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysisAndrew M Brunner, Federico Campigotto, Hossein Sadrzadeh, et al.
Future Oncology (London, England)|October 27, 2018
ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing lineAnna F Farago, Benjamin J Drapkin, Jose Antonio Lopez-Vilarino de Ramos, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
KSR1 mediates small-cell lung carcinoma tumor initiation and cisplatin resistanceDeepan Chatterjee, Robert A Svoboda, Dianna H Huisman, et al.
Molecular Cancer Research : MCR|February 10, 2025
KSR1 Mediates Small Cell Lung Carcinoma Tumor Initiation and Cisplatin ResistanceDeepan Chatterjee, Robert A Svoboda, Dianna H Huisman, et al.
Oncogene|August 17, 2024
Jumonji histone demethylases are therapeutic targets in small cell lung cancerAiden Nguyen, Clarissa G Nuñez, Tram Anh Tran, et al.
American Journal of Hematology|April 27, 2013
Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemiaAndrew M Brunner, Hossein Sadrzadeh, Yang Feng, et al.
Molecular Cell|August 18, 2022
Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progressionIoannis Sanidas, Hanjun Lee, Purva H Rumde, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Molecular Systems Biology|November 19, 2009
Analysis of the mitotic exit control system using locked levels of stable mitotic cyclinBenjamin J Drapkin, Ying Lu, Andrea L Procko, et al.
Molecular Cell|June 18, 2004
Targeted proteomic study of the cyclin-Cdk moduleVincent Archambault, Emmanuel J Chang, Benjamin J Drapkin, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|April 25, 2025
Myc family proteins: Molecular drivers of tumorigenesis and resistance in neuroendocrine tumorsHannah M Hylton-McComas, Alyssa Cordes, Konstantinos V Floros, et al.
Cancer|April 30, 2013
Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysisAndrew M Brunner, Federico Campigotto, Hossein Sadrzadeh, et al.
Future Oncology (London, England)|October 27, 2018
ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing lineAnna F Farago, Benjamin J Drapkin, Jose Antonio Lopez-Vilarino de Ramos, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
KSR1 mediates small-cell lung carcinoma tumor initiation and cisplatin resistanceDeepan Chatterjee, Robert A Svoboda, Dianna H Huisman, et al.
Molecular Cancer Research : MCR|February 10, 2025
KSR1 Mediates Small Cell Lung Carcinoma Tumor Initiation and Cisplatin ResistanceDeepan Chatterjee, Robert A Svoboda, Dianna H Huisman, et al.
Oncogene|August 17, 2024
Jumonji histone demethylases are therapeutic targets in small cell lung cancerAiden Nguyen, Clarissa G Nuñez, Tram Anh Tran, et al.
American Journal of Hematology|April 27, 2013
Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemiaAndrew M Brunner, Hossein Sadrzadeh, Yang Feng, et al.
Molecular Cell|August 18, 2022
Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progressionIoannis Sanidas, Hanjun Lee, Purva H Rumde, et al.
Pageof 4